SJ45566
SJ45566 a potent and orally active PROTAC-based LCK degrader, with a DC50 of 1.21 nM. SJ45566 can be used in the research for T‑Cell Acute Lymphoblastic Leukemia[1].
Product Specifications
CAS Number
3081937-95-0
UNSPSC
12352211
Target
PROTACs; Src
Type
Reference compound
Related Pathways
PROTAC; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/sj45566.html
Smiles
O=C(NC1=C(Cl)C=CC=C1C)C(S2)=CN=C2NC3=CC(N4CCC(CN5CCN(C6=CC=C(C7CCC(NC7=O)=O)C=C6)CC5)CC4)=NC(C)=N3
Molecular Formula
C37H42ClN9O3S
Molecular Weight
728.31
References & Citations
[1]Jamie A Jarusiewicz, et al. Development of an Orally Bioavailable LCK PROTAC Degrader as a Potential Therapeutic Approach to T-Cell Acute Lymphoblastic Leukemia. J Med Chem. 2024 Jul 8.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400743-500 1x 500 µL
Mucin 1 / EMA / Episialin / CD227 (GP1.4 + E29), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 